亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)鹽酸左氧氟沙星廠家CAS號:13392-28-4

 
 
單價 面議對比
詢價 暫無
發(fā)貨 湖北武漢市預(yù)售,付款后7天內(nèi)
型號 CAS號:13392-28-4
規(guī)格 醫(yī)藥級
過期 長期有效
更新 2011-01-30 16:15
 

湖北康寶泰精細(xì)化工有限公司(銷售部)

企業(yè)會員第15年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明

鹽酸左氧氟沙星

產(chǎn)品名稱:鹽酸左氧氟沙星

產(chǎn)品別名:1-金剛烷乙胺;鹽酸左旋氧氟沙星;1-金剛烷乙氨

英文名稱:Rimantadine HCL

CAS號:13392-28-4

分子式:C11H19N

分子量:165.28

外觀:白色或淺黃色針柱型。

含量:≥98%

用途:主要用于制造各類左旋氧氟沙星膠囊、片劑等抗菌藥制劑。本品適用于敏感細(xì)菌所引起的下列輕、中、重度感染呼吸系統(tǒng)感染:急性支氣管炎、慢性支氣管炎、慢性支氣管炎急性發(fā)作、彌漫性細(xì)支氣管炎、支氣管擴張合并感染、肺炎、咽喉炎、扁桃體炎(扁桃體周圍膿腫)。 泌尿系統(tǒng)感染:腎盂腎炎、復(fù)雜性尿路感染等。


包裝:25KG/桶

 

舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
供應(yīng)西洛他唑廠家CAS號: 73963-72-1 供應(yīng)托拉塞米廠家CAS號:56211-40-6 供應(yīng)鹽酸奧昔布寧廠家CAS號:1508-65-2 供應(yīng)呋塞米廠家CAS號:54-31-9 供應(yīng)依他尼酸廠家CAS號:58-54-8 供應(yīng)三氯噻嗪廠家CAS號:133-67-5 供應(yīng)鹽酸可樂定廠家CAS編號: 4205-91-8 供應(yīng)尼群地平廠家CASNO :39562-70-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |